Literature DB >> 15812120

Essential fatty acids, DHA and human brain.

Meharban Singh1.   

Abstract

Essential fatty acids cannot be synthesized in the body but they are required for maintenance of optimal health. There are two classes of polyunsaturated fatty acids (PUFAs)--omega-6 and omega-3. The parent omega-6 fatty acid, linoleic acid (LA) is desaturated in the body to form arachidonic acid while parent omega-3 fatty acid alpha-linolenic acid (ALA) is desaturated by microsomal enzyme system through a series of metabolic steps to form eicosapentaenoic acid (EPA) and decosahexaenoic acid (DHA). But there is a limited metabolic capability during early life to metabolize PUFAs to more active long-chain fatty acids. There is a critical role of EFAs and their metabolic products for maintenance of structural and functional integrity of central nervous system and retina. Most of the brain growth is completed by 5-6 years of age. At birth brain weight is 70% of an adult, 15% brain growth occurs during infancy and remaining brain growth is completed during preschool years. DHA is the predominant structural fatty acid in the central nervous system and retina and its availability is crucial for brain development. It is recommended that the pregnant and nursing woman should take at least 2.6 g of omega-3 fatty acids and 100-300 mg of DHA daily to look after the needs of her fetus and suckling infant. The follow-up studies have shown that infants of mothers supplemented with EFAs and DHA had higher mental processing scores, psychomotor development, eye-hand coordination and stereo acuity at 4 years of age. Intake of EFAs and DHA during preschool years may also have a beneficial role in the prevention of attention deficit hyperactivity disorder (ADHD) and enhancing learning capability and academic performance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812120

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  48 in total

1.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

Review 2.  Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.

Authors:  Prathima Nandivada; Sarah J Carlson; Melissa I Chang; Eileen Cowan; Kathleen M Gura; Mark Puder
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

3.  Omega-3 Fatty Acid Plasma Levels Before and After Supplementation: Correlations with Mood and Clinical Outcomes in the Omega-3 and Therapy Studies.

Authors:  L Eugene Arnold; Andrea S Young; Martha A Belury; Rachel M Cole; Barbara Gracious; Adina M Seidenfeld; Hannah Wolfson; Mary A Fristad
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-02-03       Impact factor: 2.576

4.  Lipid signature of neural tissues of marine and terrestrial mammals: consistency across species and habitats.

Authors:  Hillary L Glandon; Ai Ning Loh; William A McLellan; D Ann Pabst; Andrew J Westgate; Heather N Koopman
Journal:  J Comp Physiol B       Date:  2021-05-11       Impact factor: 2.200

Review 5.  Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission.

Authors:  Stanley I Rapoport; Epolia Ramadan; Mireille Basselin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-15       Impact factor: 3.072

6.  Omega-6 fatty acids down-regulate matrix metalloproteinase expression in a coronary heart disease-induced rat model.

Authors:  Nihong Lu; Yingrong Du; Haiyuan Li; Yu Luo; Bing Ouyang; Yangjun Chen; Yongrui Yang; Lixia Yang
Journal:  Int J Exp Pathol       Date:  2018-11-15       Impact factor: 1.925

7.  Effects of Chlorpyrifos on Cholinesterase and Serine Lipase Activities and Lipid Metabolism in Brains of Rainbow Trout (Oncorhynchus mykiss).

Authors:  J B Greer; J T Magnuson; K Hester; M Giroux; C Pope; T Anderson; J Liu; V Dang; N D Denslow; D Schlenk
Journal:  Toxicol Sci       Date:  2019-07-30       Impact factor: 4.849

Review 8.  ER stress and effects of DHA as an ER stress inhibitor.

Authors:  Gulnaz Begum; Lloyd Harvey; C Edward Dixon; Dandan Sun
Journal:  Transl Stroke Res       Date:  2013-08-20       Impact factor: 6.829

Review 9.  Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

Authors:  Joanne J Liu; Pnina Green; J John Mann; Stanley I Rapoport; M Elizabeth Sublette
Journal:  Brain Res       Date:  2014-12-08       Impact factor: 3.252

10.  Isolation and characterization of Taiwanese heterotrophic microalgae: screening of strains for docosahexaenoic acid (DHA) production.

Authors:  Huey-Lang Yang; Chung-Kuang Lu; Shu-Fen Chen; Young-Mao Chen; Yi-Min Chen
Journal:  Mar Biotechnol (NY)       Date:  2009-07-16       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.